Posts Tagged 'merck'

Zostavax Competitor Wins Unanimous Recommendation for Approval

shingrix wins approval recommendationAfter considering the data, every member of an FDA advisory panel convened this month voted to recommend the approval of Shingrix – a new shingles vaccine developed and marketed by GlaxoSmithKline.

Data was not based solely on efficacy, or effectiveness. Rather, the data also took the vaccine’s safety into consideration. Panel members were “very impressed” with that data on both fronts and – according to Reuters – believe that Shingrix is ...

continue reading...

New Lawsuit Claims Zostavax Shingles Link

Zostavax linked to causing shinglesA lawsuit filed in mid-July seeks compensation and damages for 18 patients who claim that Merck’s anti-shingles vaccine Zostavax actually gave them the condition they were seeking to avoid. Hailing from a variety of states, the plaintiffs have come together to sue Merck in its home state of New Jersey.

Zostavax is targeted at people aged 50 years or older and the CDC has gone so far as to issue ...

continue reading...

Appeals Court Restores Cases Against Merck Over Fosamax

merck cases restored by courtIn a 3-0 ruling, the 3rd US Circuit Court of Appeals in Philadelphia restored the claims of several hundreds of plaintiffs against Merck for their osteoporosis drug Fosamax, according to Reuters. The plaintiffs claim the company didn’t adequately warn of the risk of thigh bone fractures that the drug may carry. Trials can now proceed on failure-to-warn claims, which a lower court originally found to be pre-empted by ...

continue reading...

Flux Continues as Merck Announces Cuts

merck announces job cutsUp to 360 employees of Merck’s 7,400 New Jersey employees could either lose their jobs or see their positions relocated as the company shifts efforts toward exploratory biology.

The cuts will come from the company’s pre-clinical, discovery, and early development group. Citing a need to break into emerging research arenas, the change in strategy will result in staffing level changes in Kenilworth and Rahway, New Jersey as well as North Wales, Pennsylvania.

Positions ...

continue reading...

Merck Faces 3rd Rejection of Anesthesia Drug

merck anesthesia drug rejected by FDA for third straight timeThe pharmaceutical giant Merck faces yet another FDA rejection of its anesthesia drug Sugammadex, FierceBiotech reports. Sugammadex, obtained when Merck merged with the pharmaceutical company Shering-Plough, has been hailed as one of the top experimental drugs in Merck’s development pipeline. Over the years, however, it has experienced a number of setbacks, beginning with its first rejection by the FDA in 2008 and continuing with a second ...

continue reading...

Plaintiffs Reject Their Part Of $100 Million NuvaRing Settlement

A $100 million settlement with Merck & Co. has been finalized as 95 percent of claimants opted to receive compensation. The settlement regarding the company’s hormonal contraceptive, NuvaRing, was announced in February. There will be about 3,800 people that will receive compensation through the NuvaRing settlement.

The NuvaRing lawsuits alleged that Merck had downplayed the health risks connected to the contraceptive and did not adequately warn its users about the potential serious complications. In October 2013, ...

continue reading...
Page 1 of 2 12